Bellicum Provides Operational Update And Reports Financial Results For Fourth Quarter And Year Ended December 31, 2014

HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today reported financial results for the fourth quarter and full year ended December 31, 2014, and provided an update on the Company's recent progress.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC